Normalization of the vasculature for treatment of cancer and other diseases.
about
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesisCombination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamicsTargeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcomaReview on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and ToxicologyVascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature within the Process of Vascular Remodeling: Cellular Basis, Clinical Relevance, and Implications for Stem Cell TherapyVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideThe immunological effect of hyaluronan in tumor angiogenesisEvading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsProfile of bevacizumab and its potential in the treatment of cervical cancerRemodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyCancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?Hypoxic signaling during tissue repair and regenerative medicineTraversing the basement membrane in vivo: a diversity of strategiesVascular normalization and cancer immunotherapyExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesPushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roadsCompensatory angiogenesis and tumor refractorinessTargeting the intragraft microenvironment and the development of chronic allograft rejectionRNA interference therapy: a new solution for intracranial atherosclerosis?Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.A systems biology view of blood vessel growth and remodellingTrial Watch:: Oncolytic viruses for cancer therapyEndothelial Rictor is crucial for midgestational development and sustained and extensive FGF2-induced neovascularization in the adult.Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses MetastasesThe decidua-the maternal bed embracing the embryo-maintains the pregnancyEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Tumor-induced solid stress activates β-catenin signaling to drive malignant behavior in normal, tumor-adjacent cellsHypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaSILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markersT-type calcium channels blockers as new tools in cancer therapiesGlucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cellsTL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRIFighting the force: Potential of homeobox genes for tumor microenvironment regulationDietary Vitamin D and Its Metabolites Non-Genomically Stabilize the EndotheliumCardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review)Sonoporation enhances liposome accumulation and penetration in tumors with low EPR.Dark field optical imaging reveals vascular changes in an inducible hamster cheek pouch model during carcinogenesisAnti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma modelAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.
P2860
Q26740812-1AF03DD6-A5E9-4327-ABDB-85EFF50429F3Q26746067-239CE116-D68B-45AB-AFA7-E26AFE4BDF1EQ26747666-BB8D03CE-47A3-4BA7-A2B0-264C5CCD18B6Q26765484-45D0D558-5B83-484F-A17D-1F8251DE999CQ26765919-E2C242C1-C992-4725-9434-E10B2A1E4A33Q26770678-80723EA5-67AB-4CAC-B6E4-383FE8CEC650Q26771483-4EFC3CFF-C1CC-45B4-9528-7ED8BEEC1139Q26773795-9C144AE3-D4F5-42A1-AD5C-D1A5F2F5614BQ26774168-8BA6AE9F-6CA9-4FF9-A94F-743B0FA2649AQ26777144-41BD33D0-70ED-4727-8E54-C3F9D7D0BCFAQ26778150-4616F82A-D6B1-448C-890C-11848853264FQ26824402-19466608-840A-4F67-A0AB-144689213327Q26824769-A5EC11F8-35FB-4D51-A049-FF6531E0AE0BQ26827437-BF427080-E0B7-41AD-9548-37FC5D40583FQ26828930-1F3C7C8A-B096-48F1-88F7-6AA5F656306FQ26830075-65D1929A-1FB7-456F-BABC-67CC59E36752Q26851916-BBF00292-F69D-4EED-B9C2-FB055D256C86Q26852762-E63F2B41-359C-4604-8F79-0B1AE9951520Q26860451-4529982E-72A4-4D7A-B156-F2203C5FE298Q27000351-15EA6109-0566-4093-97A3-E5F8C90D3900Q27002209-8108C805-F059-4848-BF1B-26DF0FB8531CQ27003945-F9C12E70-0791-4EDA-B601-0087DE1F1777Q27021951-6DC3922E-D48A-429B-819D-E9F52843F556Q27304564-631593B6-D018-4F16-A43A-87A275BD2058Q27312628-2254EB42-1BDB-4725-914A-9198A4116A60Q28069835-7476E2F8-76FC-48B4-BE70-E8122AE5D1F2Q28073956-5D23EFB3-8F4E-4919-9335-FD2CEAA02237Q28080530-438BD500-AA44-488E-BE30-004500DF59A6Q28085029-386D4F75-FE44-4D62-9110-8BB2929B4F9CQ28118985-CB3ED4FA-D75F-4A96-89E6-F0165A3812B2Q28306311-50897E55-205D-4ED5-AFCE-CBA6B335A1E4Q28504783-33DB4603-2B89-47B3-BD65-E3FD56A309EDQ28540575-AD4D5F2C-0D50-40D9-931A-DC0D9EC55004Q28547302-FF36996E-0516-4A3B-9A0E-B8E937D99F4DQ28550290-926924C1-1692-4476-8116-CE0074C41C54Q30244472-3E3E928E-BA60-45E0-B102-6F51A1D3B9E1Q30358121-C2EBBC05-BFA2-4566-9E68-BF3F381634B1Q30372986-02FFB6C2-C202-4EEB-BBE9-9C8FF4D8BCE2Q30383248-B4DE179B-CAA9-4F8B-B43A-51D1E880E7BAQ30399006-338C2F5E-E4F1-48D6-A0EF-306D9D784DA2
P2860
Normalization of the vasculature for treatment of cancer and other diseases.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Normalization of the vasculature for treatment of cancer and other diseases.
@ast
Normalization of the vasculature for treatment of cancer and other diseases.
@en
type
label
Normalization of the vasculature for treatment of cancer and other diseases.
@ast
Normalization of the vasculature for treatment of cancer and other diseases.
@en
prefLabel
Normalization of the vasculature for treatment of cancer and other diseases.
@ast
Normalization of the vasculature for treatment of cancer and other diseases.
@en
P2093
P2860
P1476
Normalization of the vasculature for treatment of cancer and other diseases.
@en
P2093
Dai Fukumura
Dan G Duda
Lance L Munn
Rakesh K Jain
Yves Boucher
P2860
P304
P356
10.1152/PHYSREV.00038.2010
P577
2011-07-01T00:00:00Z